• OPEN AN ACCOUNT
Indian Indices
Sensex
78,428.95 -210.08
( -0.27%)
Global Indices
Nasdaq
53,210.99 704.96
(1.34%)
Dow Jones
7,621.51 110.79
(1.48%)
Hang Seng
63,983.92 229.02
(0.36%)
Nikkei 225
10,850.37 -17.68
(-0.16%)
Forex
USD-INR
95.40 -0.19
(-0.20%)
EUR-INR
110.00 0.21
(0.19%)
GBP-INR
128.60 0.50
(0.39%)
JPY-INR
0.61 0.01
(2.47%)

EQUITY - MARKET SCREENER

Divis Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
532488
INE361B01024
629.4942217
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DIVISLAB
73.75
220945.52
EPS(TTM)
Face Value()
Div & Yield %
112.85
2
0.36
 

zodiac ventures ltd
Artson standalone net profit rises 460.00% in the March 2026 quarter
Apr 28,2026
Net profit of Artson rose 460.00% to Rs 3.36 crore in the quarter ended March 2026 as against Rs 0.60 crore during the previous quarter ended March 2025. Sales declined 24.40% to Rs 38.75 crore in the quarter ended March 2026 as against Rs 51.26 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 10.88 crore in the year ended March 2026 as against net profit of Rs 3.48 crore during the previous year ended March 2025. Sales rose 44.06% to Rs 163.58 crore in the year ended March 2026 as against Rs 113.55 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales38.7551.26 -24 163.58113.55 44
OPM %14.327.65 --3.37-2.20 -
PBDT3.911.34 192 -13.677.19 PL
PBT3.300.79 318 -16.194.79 PL
NP3.360.60 460 -10.883.48 PL